Table 1.
HFHS-C | HFHS-FOM | HFHS-GSE | HFHS-FOM&GSE | |
---|---|---|---|---|
Weight Increase (%) | 101.8 (16.9) | 114.9 (20.3) | 93.6 (14.4) | 117.4 (20.6) |
Adiposity index (%) × | 6.62 (3.95) | 6.12 (2.62) | 4.98 (1.31) | 4.32 (1.54) |
Hepatosomatic index (%) ∆ | 2.4 (0.1) | 2.4 (0.1) | 2.3 (0.1) | 2.7 (0.4) |
Total cholesterol (mmol/L) | 3.5 (0.3) | 2.7 (0.5) *# | 3.7 (0.3) | 2.8 (0.3) *# |
Triglycerides (mmol/L) | 1.3 (0.2) | 1.6 (0.3) | 2.2 (0.2) *&$ | 1.5 (0.3) |
FFA (μg/mL) | 180.7 (24.2) | 140.2 (15.9) | 187.8 (4.5) &$ | 136.6 (25.2) *# |
TFA (μg/mL) | 2442.2 (245.0) | 2233.0 (425.4) | 3764.9 (374.1) *&$ | 2101.4 (231.1) |
HbA1c (%) | 3.25 (0.14) | 3.14 (0.12) | 3.11 (0.12) | 2.70 (0.70) |
Fasting Glucose (mg/dL) | 65.86 (3.63) | 64.14 (6.87) | 65.43 (4.69) | 67.00 (3.92) |
Plasma insulin (ng/mL) | 2.0 (0.6) | 1.6 (0.4) | 2.6 (1.2) | 1.2 (0.5) *# |
ORAC (µmol Trolox/mL plasma) | 17.7 (7.9) | 10.7 (5.7) | 19.3 (5.0) | 24.0 (3.5) & |
Plasma GPX(U/g Hb) | 0.4 (0.04) | 3.8 (0.9) *#$ | 13.4 (1.9) *&$ | 36.7 (8.5) *&# |
TBARS (mg MDA/kg liver) | 3.6 (0.7) | 10.7 (2.0) *#$ | 2.7 (0.3) | 6.6 (1.4) *&# |
Liver CRP (mg/mL) | 93.9 (53.7) | 64.3 (18.9) | 76.7 (41.7) | 60.3 (46.9) |
Liver TNFα (mg/mL) | 91.5 (47.8) | 55.2 (49.3) * | 85.2 (59.5) | 54.5 (65.4) * |
× Adiposity index: (total abdominal fat × 100)/body weight. ∆ Hepatosomatic index: (liver weight × 100)/body weight. Results are means (standard deviation) (n = 7). * P < 0.05 vs. HFHS-C; & P < 0.05 vs. HFHS-FOM; # P < 0.05 vs. HFHS-GSE; $ P < 0.05 vs. HFHS-FOM&GSE. Comparisons were performed using the one-way ANOVA and Tukey post hoc tests. These parameters have already been studied in the same cohort of animals and partially published [15,20,23]. ORAC: Oxygen Radical Absorbance Capacity; GPX: glutathione peroxidase; TFA: total fatty acids; FFA: free fatty acids.